- Home
- PHVS vs LILAK Comparison
PHVS vs LILAK Comparison
Compare PHVS & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- LILAK
- Stock Information
- Founded
- PHVS 2015
- LILAK 2017
- Country
- PHVS Switzerland
- LILAK Bermuda
- Employees
- PHVS N/A
- LILAK N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- LILAK Cable & Other Pay Television Services
- Sector
- PHVS Health Care
- LILAK Telecommunications
- Exchange
- PHVS Nasdaq
- LILAK Nasdaq
- Market Cap
- PHVS 980.9M
- LILAK 1.1B
- IPO Year
- PHVS 2021
- LILAK N/A
- Fundamental
- Price
- PHVS $20.06
- LILAK $7.90
- Analyst Decision
- PHVS Buy
- LILAK Buy
- Analyst Count
- PHVS 6
- LILAK 3
- Target Price
- PHVS $37.17
- LILAK $10.27
- AVG Volume (30 Days)
- PHVS 216.0K
- LILAK 1.6M
- Earning Date
- PHVS 08-13-2025
- LILAK 08-07-2025
- Dividend Yield
- PHVS N/A
- LILAK N/A
- EPS Growth
- PHVS N/A
- LILAK N/A
- EPS
- PHVS N/A
- LILAK N/A
- Revenue
- PHVS N/A
- LILAK $4,409,700,000.00
- Revenue This Year
- PHVS N/A
- LILAK $1.89
- Revenue Next Year
- PHVS N/A
- LILAK $3.13
- P/E Ratio
- PHVS N/A
- LILAK N/A
- Revenue Growth
- PHVS N/A
- LILAK N/A
- 52 Week Low
- PHVS $11.51
- LILAK $4.23
- 52 Week High
- PHVS $26.33
- LILAK $10.67
- Technical
- Relative Strength Index (RSI)
- PHVS 48.84
- LILAK 82.21
- Support Level
- PHVS $20.06
- LILAK $7.09
- Resistance Level
- PHVS $22.30
- LILAK $8.58
- Average True Range (ATR)
- PHVS 1.13
- LILAK 0.32
- MACD
- PHVS -0.23
- LILAK 0.08
- Stochastic Oscillator
- PHVS 22.84
- LILAK 71.74
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.